Finally, the expression of Np9 in leukemia cells is able to activate leukemia-associated signaling pathways and induce alteration in pERK, c-Myc and β-catenin expression, each of which has been shown to be altered in cancer cells [98]. This evidence concerns the gene EIF2AK3 and leukemia.